Laura Dunlap, PhD, is experienced in data collection and econometric analysis; evaluations of substance abuse and health services interventions, including process, outcome, and cost estimation, cost-effectiveness analysis, and cost-benefit analysis; and public policy analysis. Dr. Dunlap is currently the project director of the Center for Substance Abuse Treatment (CSAT)-funded Access to Recovery cross-site evaluation. For the National Institute on Drug Abuse, she has evaluated different data collection methodologies that estimate costs of substance abuse treatment services and has developed a lifetime simulation model to estimate the total costs and benefits of heroin use and methadone treatment. Dr. Dunlap has published her findings in many peer-reviewed journals, including Health Services Research, Health Economics, Contemporary Economic Policy, Applied Economics, the Journal of Public Health Policy, the Journal of Addictive Diseases, Justice Research and Policy, the Journal of Occupational Health Psychology, and the Journal of Substance Abuse Treatment.
Laura J. Dunlap
Senior Vice President of Business Operations, SSES
PhD, Health Policy and Administration, University of North Carolina, Chapel Hill
MA, Economics, University of Chicago
BA, Economics, University of Maryland, College Park